Retraction
HIF1 α/PD-L1 Axis Mediates Hypoxia-Induced Cell Apoptosis and Tumor Progression in Follicular Thyroid Carcinoma
Paper Information
Record ID:
40812
Author(s):
Journal:
Publication Date:
August 13, 2019
Retraction Date:
November 21, 2022
(3.0 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, People’s Republic of China
- Department of Ultrasonography, Cancer Hospital of University of Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, People’s Republic of China
- Department of Ultrasonography, People’s Hospital of Quzhou Kecheng, Quzhou, Zhejiang 324000, People’s Republic of China
- Department of Thyroid and Neck Surgery, People’s Hospital of Zhejiang Province, Hangzhou, Zhejiang 310006, People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (33)
33
Total Citations6
Post-Retraction(18.2%)
27
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
0
After 2+ years
298
Days since retraction (latest)
Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment
Pei Wang, Xiaoyan Wang, Changfeng Man et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Sep 2023
7 citations
7 citations
298 days after retraction
Surface Functionalization of Gold Nanoparticles for Targeting the Tumor Microenvironment to Improve Antitumor Efficiency
K. Tan, Lionel Lian Aun In, Palanirajan Vijayaraj Kumar
ACS Applied Bio Materials
Published: Jul 2023
30 citations
30 citations
233 days after retraction
Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression
Anjali Barnwal, Rohini Tamang, Sanjeev Das et al. (4 authors)
British Journal of Cancer
Open Access
Published: Jul 2023
7 citations
7 citations
224 days after retraction
Alteration of Mesenchymal Stem Cells Isolated from Glioblastoma Multiforme under the Influence of Photodynamic Treatment
Kalina Tumangelova‐Yuzeir, Krassimir Minkin, Иван Ангелов et al. (12 authors)
Current Issues in Molecular Biology
Open Access
Published: Mar 2023
3 citations
3 citations
120 days after retraction
PD-1/PD-L1 and DNA Damage Response in Cancer
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat et al. (7 authors)
Cells
Open Access
Published: Feb 2023
27 citations
27 citations
78 days after retraction
Nanotechnology-Based Approaches to Relieve Tumour Microenvironment Hypoxia via Enhanced Oxygen Delivery
Manisha Singh, Rashi Rajput, Vinayak Agarwal et al. (6 authors)
Unknown Journal
Published: Jan 2023
41 days after retraction
HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma
Lili Zhang, Shi Baixue, Mingyang Hu et al. (4 authors)
World Journal of Surgical Oncology
Open Access
Published: Nov 2022
8 citations
8 citations
17 days before retraction
Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis
Chin‐Lin Guo
Frontiers in Cell and Developmental Biology
Open Access
Published: Jun 2022
10 citations
10 citations
160 days before retraction
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Qinghua Wu, You Li, Eugenie Nepovimová et al. (7 authors)
Journal of Hematology & Oncology
Open Access
Published: Jun 2022
292 citations
292 citations
171 days before retraction
Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers
Giimel Ajnai, Chun‐Chia Cheng, Tzu-Chun Kan et al. (7 authors)
Pharmaceutics
Open Access
Published: Apr 2022
20 citations
20 citations
223 days before retraction
Analysis of anti‐apoptotic PVT1 oncogene and apoptosis‐related proteins (p53, Bcl2, PD‐1, and PD‐L1) expression in thyroid carcinoma
Afaf T. Ibrahiem, Amin Khalid Makhdoom, Khalid Alanazi et al. (8 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: Apr 2022
5 citations
5 citations
228 days before retraction
PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC
Dongho Geum, Dae‐Seok Hwang, Chang Hun Lee et al. (7 authors)
Life
Open Access
Published: Feb 2022
7 citations
7 citations
290 days before retraction
Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion
Sumiyo Saburi, Takahiro Tsujikawa, Aya Miyagawa‐Hayashino et al. (14 authors)
Modern Pathology
Open Access
Published: Dec 2021
10 citations
10 citations
332 days before retraction
The potential role of vitamin C in empowering cancer immunotherapy
Takwa Bedhiafi, Varghese Inchakalody, Queenie Fernandes et al. (8 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Dec 2021
60 citations
60 citations
336 days before retraction
Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
Lisha Bao, Tong Xu, Xixuan Lu et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Dec 2021
23 citations
23 citations
354 days before retraction
Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
Zhe Deng, Yong-Jie Teng, Qing Zhou et al. (13 authors)
World Journal of Gastrointestinal Oncology
Open Access
Published: Nov 2021
9 citations
9 citations
374 days before retraction
Revisiting the HIF switch in the tumor and its immune microenvironment
Sophie J. Cowman, Mei Yee Koh
Trends in cancer
Open Access
Published: Nov 2021
157 citations
157 citations
382 days before retraction
Heat shock protein 70 attenuates hypoxia‑induced apoptosis of pulmonary microvascular endothelial cells isolated from neonatal rats
Jing Cao, Lingjie Yang, Le Wang et al. (7 authors)
Molecular Medicine Reports
Open Access
Published: Jul 2021
16 citations
16 citations
479 days before retraction
Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles
Zeting Yuan, Guohua Fan, Honglei Wu et al. (11 authors)
Molecular Therapy
Open Access
Published: May 2021
101 citations
101 citations
549 days before retraction
The regulation of immune checkpoints by the hypoxic tumor microenvironment
Min Hu, Yongfu Li, Yuting Lu et al. (8 authors)
PeerJ
Open Access
Published: May 2021
35 citations
35 citations
563 days before retraction
Association between programmed cell death ligand 1 expression and thyroid cancer
Baoyu Wan, Pengyi Deng, Wenli Dai et al. (9 authors)
Medicine
Open Access
Published: Apr 2021
15 citations
15 citations
592 days before retraction
Anticipating metastasis through electrochemical immunosensing of tumor hypoxia biomarkers
Cristina Muñoz‐San Martín, María Gamella, Marı́a Pedrero et al. (10 authors)
Analytical and Bioanalytical Chemistry
Published: Feb 2021
21 citations
21 citations
633 days before retraction
From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer
Grégoire D’Andréa, Sandra Lassalle, N. Guevara et al. (5 authors)
Theranostics
Open Access
Published: Dec 2020
37 citations
37 citations
705 days before retraction
PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma
Zihan Zhou, Dianbin Mu, Dexian Zhang et al. (8 authors)
Cancer Management and Research
Open Access
Published: Dec 2020
14 citations
14 citations
720 days before retraction
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
Katie Hudson, Neil A. Cross, Nicola Jordan et al. (4 authors)
Frontiers in Immunology
Open Access
Published: Oct 2020
170 citations
170 citations
761 days before retraction
Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
Yi‐Ting Chen, Jieling Ning, Wenjie Cao et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Oct 2020
93 citations
93 citations
761 days before retraction
PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer
Haiying Zhu, Chengyong Du, Meng Yuan et al. (7 authors)
Drug Discovery Today
Published: Jul 2020
30 citations
30 citations
863 days before retraction
Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma
Authors Li Zhou, Xuezhou Wang, Wenwen Yu et al. (11 authors)
Pathology - Research and Practice
Published: Jun 2020
18 citations
18 citations
875 days before retraction
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
Cao Dai Phung, Tuan Hiep Tran, Le Minh Pham et al. (7 authors)
Journal of Controlled Release
Published: May 2020
103 citations
103 citations
911 days before retraction
Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α
Guanzhong Qiu, Qiang Liu, Xiaogang Wang et al. (6 authors)
Life Sciences
Published: Feb 2020
19 citations
19 citations
1010 days before retraction
Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs
Christian Bailly
Life Sciences
Published: Feb 2020
84 citations
84 citations
1020 days before retraction
<p>miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways</p>
X Zhang, Lan Xu, Ting Yang
OncoTargets and Therapy
Open Access
Published: Jan 2020
22 citations
22 citations
1055 days before retraction
Immune Microenvironment of Thyroid Cancer
Hongyu Yin, Yemei Tang, Yujia Guo et al. (4 authors)
Journal of Cancer
Open Access
Published: Jan 2020
38 citations
38 citations
1055 days before retraction
Quick Stats
Total Citations:
33
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025